About Rasio
|
Rasio Therapeutics, a drug development spin-off of SilcsBio, LLC, is a U.S. based therapeutics company harnessing the full power of next generation computer aided drug design to bring novel medicines to the clinic.
|
|
Our mission addresses unmet patient needs through modeling of novel/deep cell binding regions. Rasio designs molecules to fit those regions and enhance treatment for cancer and other diseases. We work with the best researchers – and use the best computational chemistry software – to create effective therapies that only Rasio can develop.
|
|
|
Our research and dedicated focus at Rasio Therapeutics puts patients first. To help those suffering from cancer and other diseases, we manage novel drug development from discovery to delivery, partnering with world-class entities as we progress each product.
|
Business Model And Corporate Structure
|
Rasio Therapeutics is a lean, semi-virtual, and asset-centric. Our core strategy is to keep overhead and infrastructure costs low while accelerating the ability to trigger liquidity events. With this model, we are running multiple drug discovery and development programs in parallel.
|
|
© 2021 Rasio All Rights Reserved
